138 related articles for article (PubMed ID: 7717988)
1. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor.
Kreitman RJ; Pastan I
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):29-37. PubMed ID: 7717988
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin.
Teter K; Holmes RK
Infect Immun; 2002 Nov; 70(11):6172-9. PubMed ID: 12379695
[TBL] [Abstract][Full Text] [Related]
3. Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation.
Zhan J; Stayton P; Press OW
Cancer Immunol Immunother; 1998 Mar; 46(1):55-60. PubMed ID: 9520293
[TBL] [Abstract][Full Text] [Related]
4. Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.
Mazor R; Vassall AN; Eberle JA; Beers R; Weldon JE; Venzon DJ; Tsang KY; Benhar I; Pastan I
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3597-603. PubMed ID: 23213206
[TBL] [Abstract][Full Text] [Related]
5. KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p.
Majoul I; Sohn K; Wieland FT; Pepperkok R; Pizza M; Hillemann J; Söling HD
J Cell Biol; 1998 Nov; 143(3):601-12. PubMed ID: 9813083
[TBL] [Abstract][Full Text] [Related]
6. The KDEL trafficking receptor exploits pH to tune the strength of an unusual short hydrogen bond.
Wu Z; Newstead S; Biggin PC
Sci Rep; 2020 Oct; 10(1):16903. PubMed ID: 33037300
[TBL] [Abstract][Full Text] [Related]
7. A divalent recombinant immunotoxin formed by a disulfide bond between the extension peptide chains.
Park JH; Kwon HW; Chung HK; Kim IH; Ahn K; Choi EJ; Pastan I; Choe M
Mol Cells; 2001 Dec; 12(3):398-402. PubMed ID: 11804341
[TBL] [Abstract][Full Text] [Related]
8. New tricks for KDEL receptors.
Li MY; Bruzzone R; Wang PG
Oncotarget; 2015 Oct; 6(31):30425-6. PubMed ID: 26356567
[No Abstract] [Full Text] [Related]
9. C-terminal KDEL sequence of a KDEL-tailed cysteine proteinase (sulfhydryl-endopeptidase) is involved in formation of KDEL vesicle and in efficient vacuolar transport of sulfhydryl-endopeptidase.
Okamoto T; Shimada T; Hara-Nishimura I; Nishimura M; Minamikawa T
Plant Physiol; 2003 Aug; 132(4):1892-900. PubMed ID: 12913146
[TBL] [Abstract][Full Text] [Related]
10. Does the KDEL receptor cycle between the Golgi and the ER?
Aniento F; Robinson DG
Nat Commun; 2024 Mar; 15(1):2455. PubMed ID: 38509061
[No Abstract] [Full Text] [Related]
11. Reply to: Does the KDEL receptor cycle between the Golgi and the ER?
Denecke J
Nat Commun; 2024 Mar; 15(1):2454. PubMed ID: 38509079
[No Abstract] [Full Text] [Related]
12. Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer.
Fischer A; Masilamani AP; Schultze-Seemann S; Wolf I; Gratzke C; Fuchs H; Wolf P
J Cancer; 2023; 14(16):3039-3049. PubMed ID: 37859824
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of the antimicrobial peptide BP100 for expression in plant systems.
Badosa E; Moiset G; Montesinos L; Talleda M; Bardají E; Feliu L; Planas M; Montesinos E
PLoS One; 2013; 8(12):e85515. PubMed ID: 24376887
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for pH sensing in the KDEL trafficking receptor.
Wu Z; Smith K; Gerondopoulos A; Sobajima T; Parker JL; Barr FA; Newstead S; Biggin PC
Structure; 2024 Apr; ():. PubMed ID: 38626766
[TBL] [Abstract][Full Text] [Related]
15. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum.
Jackson ME; Simpson JC; Girod A; Pepperkok R; Roberts LM; Lord JM
J Cell Sci; 1999 Feb; 112 ( Pt 4)():467-75. PubMed ID: 9914159
[TBL] [Abstract][Full Text] [Related]
16. Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with
Nguyen MQ; Kim DH; Shim HJ; Ta HKK; Vu TL; Nguyen TKO; Lim JC; Choe H
Mol Cells; 2023 Dec; 46(12):764-777. PubMed ID: 38052492
[TBL] [Abstract][Full Text] [Related]
17. Cancer Drug Delivery Systems Using Bacterial Toxin Translocation Mechanisms.
Yin L; Thaker H
Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508840
[TBL] [Abstract][Full Text] [Related]
18. Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25.
Peng Y; Wu Z; Pang Z; Zhang L; Song D; Liu F; Li Y; Lin T
Microb Cell Fact; 2023 May; 22(1):100. PubMed ID: 37198642
[TBL] [Abstract][Full Text] [Related]
19. Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy.
Shariaty Vaziri Z; Shafiee F; Akbari V
Biotechnol Lett; 2023 Apr; 45(4):537-550. PubMed ID: 36807722
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity.
Jun SY; Kim DS; Kim YS
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
